Glaxosmithkline | GSK - Денежные средства и эквиваленты

Биржевая цена
52.25
Изменение за день
-6.87 -11.62%
Ежемесячно
-11.83%
Ежегодный
33.15%
Q1 прогноз
50.74




Денежные средства и эквиваленты Изменить Дата
AbbVie USD 5.23B 400M 2025-12
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Aurora Cannabis CAD 56.36M 39.33M 2025-12
Bausch Health Companies USD 1.31B 419M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Canopy Growth CAD 371.32M 73.26M 2025-12
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Drreddys Laboratories INR 18.66B 9.65B 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
GlaxoSmithKline GBP 3.3B 303M 2025-09
Glaxosmithkline GBP 3.3B 303M 2025-09
J&J USD 19.71B 1.48B 2025-12
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pacira USD 158.54M 10.96M 2025-12
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Phibro Animal Health USD 55.49M 17.28M 2025-12
Prestige Brands USD 62.37M 56.73M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Takeda JPY 654.94B 26.55B 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Zoetis USD 2.08B 649M 2025-09